Review
[New trends in chemotherapy of systemic lupus erythematosus: treatment with mycophenolate mofetil]
[Article in
Russian]
- PMID: 12043258
Item in Clipboard
Review
[New trends in chemotherapy of systemic lupus erythematosus: treatment with mycophenolate mofetil]
[Article in
Russian]
Klin Med (Mosk).
2002.
Abstract
The review covers current issues of pharmacotherapy of systemic lupus erythematosus (SLE) with a focus on a novel immunodepressant mofetil microphenolate (MM) which is not inferior in efficiency to a conventional anti-SLE drug cyclophosphamide which has a worse tolerance.
Similar articles
-
Mycophenolic acid exposure and complement fraction C3 influence inosine 5'-monophosphate dehydrogenase activity in systemic lupus erythematosus.Ann Clin Biochem. 2017 Jul;54(4):490-494. doi: 10.1177/0004563216667753. Epub 2016 Aug 17. Ann Clin Biochem. 2017. PMID: 27538768
-
Mycophenolate mofetil and systemic lupus erythematosus: an overview.Lupus. 2005;14 Suppl 1:s9-11. doi: 10.1191/0961203305lu2111oa. Lupus. 2005. PMID: 15803925 Review.
-
Beneficial effect of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil on survival and severity of glomerulonephritis in systemic lupus erythematosus (SLE)-prone MRLlpr/lpr mice.Clin Exp Immunol. 1999 Jun;116(3):534-41. doi: 10.1046/j.1365-2249.1999.00901.x. Clin Exp Immunol. 1999. PMID: 10361247 Free PMC article.
-
[Progress and perspectives in the treatment of systemic lupus erythematosus].Przegl Lek. 2005;62(9):894-9. Przegl Lek. 2005. PMID: 16541725 Review. Polish.
-
Hypersensitivity to mycophenolate mofetil in systemic lupus erythematosus: diagnostic measures and successful desensitization.Int Arch Allergy Immunol. 2005 Dec;138(4):334-6. doi: 10.1159/000088873. Epub 2005 Oct 13. Int Arch Allergy Immunol. 2005. PMID: 16224194
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical